School-based health clinics benefit rural NYS communities

In a rural part of upstate New York, students with access to school-based health centers received more medical care and missed less school, Cornell researchers found.

Library expands video streaming resources 

From Hollywood blockbusters to independent films, visual resources are just a couple of clicks away for Cornell students, faculty, and staff.

Around Cornell

Using broad race categories in medicine hides true health risks

Many medical studies record a patient’s race using only the broad categories from the U.S. Census, which may conceal racial health disparities, a new Cornell-led study reports.

Potential neuropathic pain treatment shows promise in preclinical tests

A non-opioid designer molecule for treating chronic neuropathic pain has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.

Hep C treatment initiation low among Medicaid recipients

Only one in five Medicaid enrollees diagnosed with hepatitis C virus started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.

Mineralization of bone matrix regulates tumor cell growth

An interdisciplinary Cornell team has identified a new mechanism regulating tumor growth in the skeleton, the primary site of breast cancer metastasis: mineralization of the bone matrix.

Young African leaders find inspiration, confidence at Cornell

A cohort of 25 Mandela Washington Fellows spent the summer on campus developing their leadership and expertise, in a program they said will have enduring impact on their lives and work.

Sonnenberg receives NIH grant for IBD research

Weill Cornell Medicine associate professor Gregory F. Sonnenberg has been awarded a five-year, $3.26 million grant from the National Institutes of Health to investigate the underlying mechanisms of inflammatory bowel disease.

Study to compare heart procedure benefits in underrepresented groups

A multi-institution team led by a Weill Cornell Medicine scientist has been approved for $30 million in funding from the Patient-Centered Outcomes Research Institute to study heart procedure outcomes in underrepresented groups.